We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$5.97M
Cap. Flow
+$10.1M
Cap. Flow %
3%
Top 10 Hldgs %
27.92%
Holding
666
New
47
Increased
170
Reduced
94
Closed
28

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.02M
2
WRB icon
W.R. Berkley
WRB
+$1.01M
3
AMZN icon
Amazon
AMZN
+$842K
4
GD icon
General Dynamics
GD
+$368K
5
NTR icon
Nutrien
NTR
+$344K

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$501K
2
CVS icon
CVS Health
CVS
+$368K
3
BMY icon
Bristol-Myers Squibb
BMY
+$359K
4
PLTR icon
Palantir
PLTR
+$244K
5
FISV
Fiserv Inc
FISV
+$204K

Sector Composition

Rank Sector Weight
1 Technology 17.74%
2 Healthcare 14.93%
3 Financials 13.98%
4 Industrials 10.27%
5 Communication Services 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVS icon
226
Novartis
NVS
$291B
$153K 0.05%
1,573
-400
-20% -$42.7K
HIG icon
227
Hartford Financial Services
HIG
$38.9B
$152K 0.05%
1,393
– –
AVY icon
228
Avery Dennison
AVY
$13.3B
$152K 0.05%
810
-100
-11% -$20.4K
GEV icon
229
GE Vernova
GEV
$271B
$150K 0.04%
456
+75
+20% +$23.4K
FCX icon
230
Freeport-McMoran
FCX
$96.7B
$150K 0.04%
3,934
+1,250
+47% +$55.9K
ABM icon
231
ABM Industries
ABM
$2.88B
$149K 0.04%
2,916
– –
IHE icon
232
iShares US Pharmaceuticals ETF
IHE
$1.62B
$148K 0.04%
2,247
– –
VGK icon
233
Vanguard FTSE Europe ETF
VGK
$31.1B
$148K 0.04%
2,325
– –
GILD icon
234
Gilead Sciences
GILD
$168B
$145K 0.04%
1,575
-500
-24% -$45K
DVY icon
235
iShares Select Dividend ETF
DVY
$23.8B
$144K 0.04%
1,094
– –
FIS icon
236
Fidelity National Information Services
FIS
$22.9B
$142K 0.04%
1,752
-198
-10% -$17.1K
SJNK icon
237
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.76B
$141K 0.04%
5,577
+949
+21% +$24.2K
VTWV icon
238
Vanguard Russell 2000 Value ETF
VTWV
$1.32B
$137K 0.04%
950
– –
VIG icon
239
Vanguard Dividend Appreciation ETF
VIG
$114B
$136K 0.04%
695
+200
+40% +$39.9K
HSY icon
240
Hershey
HSY
$36B
$134K 0.04%
789
+101
+15% +$18.1K
ES icon
241
Eversource Energy
ES
$27.3B
$133K 0.04%
2,316
– –
CB icon
242
Chubb
CB
$134B
$130K 0.04%
470
– –
IFF icon
243
International Flavors & Fragrances
IFF
$20.7B
$130K 0.04%
1,533
– –
GIS icon
244
General Mills
GIS
$19.3B
$128K 0.04%
2,014
– –
COP icon
245
ConocoPhillips
COP
$144B
$125K 0.04%
1,261
+228
+22% +$24.2K
STT icon
246
State Street
STT
$50.9B
$124K 0.04%
1,260
– –
BUD icon
247
AB InBev
BUD
$167B
$121K 0.04%
2,425
+50
+2% +$2.89K
BF.B icon
248
Brown-Forman Class B
BF.B
$13.1B
$119K 0.04%
3,142
– –
MDT icon
249
Medtronic
MDT
$110B
$119K 0.04%
1,487
+202
+16% +$17.5K
HLT icon
250
Hilton Worldwide
HLT
$70.2B
$116K 0.03%
470
+345
+276% +$84.4K
8 9
10
11 12

Similar funds

JGCM
Joseph Group Capital Management Columbus, Ohio $400M AUM 18.42% 1-Year Est. Return
AIM
Alpine Investment Management Hong Kong $401M AUM 17.09% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return

Brown, Lisle/Cummings's Q4 2024 Portfolio in Review

As of Q4 2024, Brown, Lisle/Cummings held 666 positions worth $335M, up 1.8% from $329M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $10.1M of net new capital in Q4 2024, opening 47 new positions and adding to 170 existing holdings. Its largest new stake was W.R. Berkley: 16,780 shares worth $982K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was T. Rowe Price, an estimated $501K trimmed.

  • Brown, Lisle/Cummings's largest Q4 2024 buy was W.R. Berkley: 16,780 shares worth $982K.
  • Brown, Lisle/Cummings added most to Eli Lilly in Q4 2024, an estimated $1.02M increase.
  • Brown, Lisle/Cummings's biggest Q4 2024 reduction was T. Rowe Price, cutting an estimated $501K.
  • Brown, Lisle/Cummings fully exited TransUnion in Q4 2024, selling an estimated $20.9K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $335M portfolio in Q4 2024.
  • Brown, Lisle/Cummings opened 47 new positions and closed 28 in Q4 2024.
  • Brown, Lisle/Cummings's portfolio value rose 1.8% quarter-over-quarter to $335M.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2024, filed 27 Jan 2025.